|
1
|
He Y, Fan Q, Cai T, Huang W, Xie X, Wen Y
and Shi Z: Molecular mechanisms of the action of arctigenin in
cancer. Biomed Pharmacother. 108:403–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maxwell T, Chun SY, Lee KS, Kim S and Nam
KS: The anti-metastatic effects of the phytoestrogen arctigenin on
human breast cancer cell lines regardless of the status of ER
expression. Int J Oncol. 50:727–735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Li W, Jin E, He Q, Yan W, Yang H,
Gong S, Guo Y, Fu S, Chen X, et al: The antiviral activity of
arctigenin in traditional Chinese medicine on porcine circovirus
type 2. Res Vet Sci. 106:159–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen YF, Liu L, Chen WC, Hu Y, Zhu B and
Wang GX: Evaluation on the antiviral activity of arctigenin against
spring viraemia of carp virus. Aquaculture. 483:252–262. 2018.
View Article : Google Scholar
|
|
5
|
Hayashi K, Narutaki K, Nagaoka Y, Hayashi
T and Uesato S: Therapeutic effect of arctiin and arctigenin in
immunocompetent and immunocompromised mice infected with influenza
A virus. Biol Pharm Bull. 33:1199–1205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang CZ, Wu SC, Chang CM, Lin CL and Kwan
AL: Arctigenin, a potent ingredient of arctium Lappa L., induces
endothelial nitric oxide synthase and attenuates subarachnoid
hemorrhage-induced vasospasm through PI3K/Akt pathway in a rat
model. Biomed Res Int. 2015:4902092015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu RM, Sun YY, Zhou TT, Zhu ZY, Zhuang JJ,
Tang X, Chen J, Hu LH and Shen X: Arctigenin enhances swimming
endurance of sedentary rats partially by regulation of antioxidant
pathways. Acta Pharmacol Sin. 35:1274–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeong YH, Park JS, Kim DH and Kim HS:
Arctigenin increases hemeoxygenase-1 gene expression by modulating
PI3K/AKT signaling pathway in rat primary astrocytes. Biomol Ther
(Seoul). 22:497–502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Q, Yang M and Zuo Z: Overview of the
anti-inflammatory effects, pharmacokinetic properties and clinical
efficacies of arctigenin and arctiin from Arctium lappa L.
Acta Pharmacol Sin. 39:787–801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao F, Wang L and Liu K: In vitro
anti-inflammatory effects of arctigenin, a lignan from Arctium
lappa L., through inhibition on NOS pathway. J Ethnopharmacol.
122:457–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hyam SR, Lee IA, Gu W, Kim KA, Jeong JJ,
Jang SE, Han MJ and Kim DH: Arctigenin ameliorates inflammation in
vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing
M1 macrophages to M2-like macrophages. Eur J Pharmacol. 708:21–29.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maxwell T, Lee KS, Kim S and Nam KS:
Arctigenin inhibits the activation of the mTOR pathway, resulting
in autophagic cell death and decreased ER expression in ER-positive
human breast cancer cells. Int J Oncol. 52:1339–1349.
2018.PubMed/NCBI
|
|
13
|
Lou CH, Zhu Z, Zhao Y, Zhu R and Zhao H:
Arctigenin, a lignan from Arctium lappa L., inhibits
metastasis of human breast cancer cells through the downregulation
of MMP-2/-9 and heparanase in MDA-MB-231 cells. Oncol Rep.
37:179–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng T, Cao W, Shen W, Zhang L, Gu X, Guo
Y, Tsai HI, Liu X, Li J, Zhang J, et al: Arctigenin inhibits STAT3
and exhibits anticancer potential in human triple-negative breast
cancer therapy. Oncotarget. 8:329–344. 2017.PubMed/NCBI
|
|
15
|
Hsieh CJ, Kuo PL, Hsu YC, Huang YF, Tsai
EM and Hsu YL: Arctigenin, a dietary phytoestrogen, induces
apoptosis of estrogen receptor-negative breast cancer cells through
the ROS/p38 MAPK pathway and epigenetic regulation. Free Radical
Bio Med. 67:159–170. 2014. View Article : Google Scholar
|
|
16
|
Awale S, Lu J, Kalauni SK, Kurashima Y,
Tezuka Y, Kadota S and Esumi H: Identification of arctigenin as an
antitumor agent having the ability to eliminate the tolerance of
cancer cells to nutrient starvation. Cancer Res. 66:1751–1757.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Tan YJ, Lu ZZ, Li BB, Sun CH, Li T,
Zhao LL, Liu Z, Zhang GM, Yao JC and Li J: Arctigenin inhibits
liver cancer tumorigenesis by inhibiting gankyrin expression via
C/EBP and PPARα. Front Pharmacol. 9:2682018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li QC, Liang Y, Tian Y and Hu GR:
Arctigenin induces apoptosis in colon cancer cells through
ROS/p38MAPK pathway. J Buon. 21:87–94. 2016.PubMed/NCBI
|
|
19
|
Tungsukruthai S, Petpiroon N and
Chanvorachote P: Molecular mechanisms of breast cancer metastasis
and potential anti-metastatic compounds. Anticancer Res.
38:2607–2618. 2018.PubMed/NCBI
|
|
20
|
Campone M, Valo I, Jezequel P, Moreau M,
Boissard A, Campion L, Loussouarn D, Verriele V, Coqueret O and
Guette C: Prediction of recurrence and survival for triple-negative
breast cancer (TNBC) by a protein signature in tissue samples. Mol
Cell Proteomics. 14:2936–2946. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gautam P, Karhinen L, Szwajda A, Jha SK,
Yadav B, Aittokallio T and Wennerberg K: Identification of
selective cytotoxic and synthetic lethal drug responses in triple
negative breast cancer cells. Mol Cancer. 15:342016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DC and Radisky ES: Tumor cell-produced matrix
metalloproteinase 9 (MMP-9) drives malignant progression and
metastasis of basal-like triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee KS, Shin JS and Nam KS: Effect of
proton beam irradiation on the regulation of metastasis-enhancing
factors in MCF-7 human breast cancer cells. J Korean Phys Soc.
63:1373–1378. 2013. View Article : Google Scholar
|
|
24
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: Changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brinckerhoff CE and Matrisian LM:
Timeline-Matrix metalloproteinases: A tail of a frog that became a
prince. Nat Rev Mol Cell Bio. 3:207–214. 2002. View Article : Google Scholar
|
|
26
|
Ye S, Eriksson P, Hamsten A, Kurkinen M,
Humphries SE and Henney AM: Progression of coronary atherosclerosis
is associated with a common genetic variant of the human
stromelysin-1 promoter which results in reduced gene expression. J
Biol Chem. 271:13055–13060. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steenport M, Khan KM, Du B, Barnhard SE,
Dannenberg AJ and Falcone DJ: Matrix metalloproteinase (MMP)-1 and
MMP-3 induce macrophage MMP-9: Evidence for the Role of TNF-alpha
and Cyclooxygenase-2. J Immunol. 183:8119–8127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Flores-Pliego A, Espejel-Nuñez A,
Castillo-Castrejon M, Meraz-Cruz N, Beltran-Montoya J,
Zaga-Clavellina V, Nava-Salazar S, Sanchez-Martinez M,
Vadillo-Ortega F and Estrada-Gutierrez G: Matrix
metalloproteinase-3 (MMP-3) is an endogenous activator of the MMP-9
secreted by placental leukocytes: Implication in human labor. PLoS
One. 10:e01453662015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stasinopoulos I, O'Brien DR, Wildes F,
Glunde K and Bhujvalla ZM: Silencing of cyclooxygenase-2 inhibits
metastasis and delays tumor onset of poorly differentiated
metastatic breast cancer cells. Mol Cancer Res. 5:435–442. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bu X, Zhao C and Dai X: Involvement of
COX-2/PGE2 pathway in the upregulation of MMP-9 expression in
pancreatic cancer. Gastroenterol Res Prac. 2011:2142692011.
|
|
31
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Low HB and Zhang Y: Regulatory roles of
MAPK phosphatases in cancer. Immune Netw. 16:85–98. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastasis
Rev. 22:395–403. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang M and Huang CZ: Mitogen-activated
protein kinase signaling pathway and invasion and metastasis of
gastric cancer. World J Gastroenterol. 21:11673–11679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benbow U and Brinckerhoff CE: The AP-1
site and MMP gene regulation: What is all the fuss about? Matrix
Biol. 15:519–526. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mishra M, Flaga J and Kowluru RA:
Molecular mechanism of transcriptional regulation of matrix
metalloproteinase-9 in diabetic retinopathy. J Cell Physiol.
231:1709–1718. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang F, Cao J, Liu Q, Zou Y, Li H and Yin
T: MAPK/ERK signal pathway involved expression of COX-2 and VEGF by
IL-1β induced in human endometriosis stromal cells in vitro. Int J
Clin Exp Pathol. 6:2129–2136. 2013.PubMed/NCBI
|
|
39
|
Karin M: The regulation of AP-1 activity
by mitogen-activated protein kinases. J Biol Chem. 270:16483–16486.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weekes D, Kashima TG, Zandueta C, Perurena
N, Thomas DP, Sunters A, Vuillier C, Bozec A, El-Emir E, Miletich
I, et al: Regulation of osteosarcoma cell lung metastasis by the
c-Fos/AP-1 target FGFR1. Oncogene. 35:2852–2861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Pu X, Shi M, Chen L, Qian L, Song
Y, Yuan G, Zhang H, Yu M, Hu M, et al: c-Jun, a crucial molecule in
metastasis of breast cancer and potential target for biotherapy.
Oncol Rep. 18:1207–1212. 2007.PubMed/NCBI
|
|
42
|
Malnou CE, Brockly F, Favard C,
Moquet-Torcy G, Piechaczyk M and Jariel-Encontre I:
Heterodimerization with different Jun proteins controls c-Fos
intranuclear dynamics and distribution. J Biol Chem. 285:6552–6562.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
During A, Debouche C, Raas T and
Larondelle Y: Among plant lignans, pinoresinol has the strongest
antiinflammatory properties in human intestinal Caco-2 cells. J
Nutr. 142:1798–1805. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mehner C, Miller E, Nassar A, Bamlet WR,
Radisky ES and Radisky DC: Tumor cell expression of MMP3 as a
prognostic factor for poor survival in pancreatic, pulmonary, and
mammary carcinoma. Genes Cancer. 6:480–489. 2015.PubMed/NCBI
|
|
46
|
Chu C, Liu X, Bai X, Zhao T, Wang M, Xu R,
Li M, Hu Y, Li W, Yang L, et al: MiR-519d suppresses breast cancer
tumorigenesis and metastasis via targeting MMP3. Int J Biol Sci.
14:228–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nalla AK, Gorantla B, Gondi CS, Lakka SS
and Rao JS: Targeting MMP-9, uPAR, and cathepsin B inhibits
invasion, migration and activates apoptosis in prostate cancer
cells. Cancer Gene Ther. 17:599–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xu DM, Mckee CM, Cao YH, Ding YC, Kessler
BM and Muschel RJ: Matrix metalloproteinase-9 regulates tumor cell
invasion through cleavage of protease nexin-1. Cancer Res.
70:6988–6998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Park CH, Lee MJ, Ahn J, Kim S, Kim HH, Kim
KH, Eun HC and Chung JH: Heat shock-induced matrix
metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and
JNK activation and via an autocrine interleukin-6 loop. J Invest
Dermatol. 123:1012–1019. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hannemann N, Jordan J, Paul S, Reid S,
Baenkler HW, Sonnewald S, Bäuerle T, Vera J, Schett G and Bozec A:
The AP-1 Transcription factor c-Jun promotes arthritis by
regulating cyclooxygenase-2 and arginase-1 expression in
macrophages. J Immunol. 198:3605–3614. 2017. View Article : Google Scholar : PubMed/NCBI
|
